Abstract:Previous research suggests that the neuropeptide orexin A contributes to sympathetic blood pressure (BP) control inasmuch as hypothalamic injection of orexin A increases sympathetic vasomotor tone and arterial BP in rodents. In humans with narcolepsy, a disorder associated with loss of orexin-producing neurons, vasoconstrictive muscle sympathetic nerve activity (MSNA) is reduced. Since intranasally administered oligopeptides like orexin are known to modulate brain function, we investigated the effect of intranasal orexin A on vascular sympathetic baroreflex function in healthy humans. In a balanced, double-blind crossover study, orexin A (500 nmol) and placebo, respectively, were intranasally administered to 10 lean healthy males (age 25.8 ± 4.6 yr). MSNA was assessed microneurographically before and 30-45 min after either substance administration. Additionally, baroreflex was challenged via graded infusions of vasoactive drugs before and after substance administration. Baroreflex function was defined as the correlation of BP with MSNA and heart rate. Intranasal orexin A compared with placebo induced a significant increase in resting MSNA from pre-to postadministration [Δburst rate, orexin A vs. placebo: +5.8 ± 0.8 vs. +2.1 ± 0.6 bursts/min, P = 0.007; total activity 169 ± 11.5% vs. 115 ± 5.0%; P = 0.002]. BP, heart rate, and sympathovagal balance to the heart, as represented by heart rate variability (HRV), as well as baroreflex sensitivity during the vasoactive challenge were not altered. Intranasally administered orexin A acutely induced vasoconstrictory sympathoactivation in healthy male humans. This result suggests that orexin A mediates upward resetting of the vascular baroreflex set point at centers superordinate to the mere baroreflex feedback loop.NEW & NOTEWORTHY Our pilot study adds another important part to the complex network of neuroendocrine-sympathetic interaction. Our results demonstrate that intranasal orexin A elicits an excitatory effect on sympathetic vascular tone superordinate to mere baroreflex feedback regulation. This resetting of the baroreflex set point suggests an activation of hypothalamic core centers such as the paraventricular nucleus (PVN). The role of the orexinergic system in the development of neurogenic arterial hypertension warrants further investigations.

Orexin A induced increases in rat locus coeruleus neuronal activity are attenuated by systemic administration of OX1R and OX2R antagonists

Both Ox1R and Ox2R orexin receptors contribute to the cardiorespiratory response evoked from the perifornical hypothalamus

Central action of orexin-A on the neural activity of hypothalamic paraventricular nucleus neuron

Orexin-A directly depolarizes dorsomedial hypothalamic neurons, including those innervating the rostral ventrolateral medulla

Both Ox1r and Ox2r orexin receptors contribute to the cardiovascular and locomotor components of the novelty stress response in the rat

Orexin A regulates cardiovascular responses in stress-induced hypertensive rats.

Central Actions of Orexin-a on Hypothalamic Paraventricular Nucleus Activity in Conscious, Freely Moving Rats

Implicación de los canales L de Ca2+ en el efecto de la orexina A sobre la entrada de Ca2+ extracelular en neuronas de la corteza prefrontal de rata

Effects of orexin A on excitatory synaptic transmission in the rat nucleus tractus solitarius

Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition

Orexin-A differentially modulates inhibitory and excitatory synaptic transmission in rat inner retina

Orexin A Increases Sympathetic Nerve Activity Through Promoting Expression of Proinflammatory Cytokines in Sprague Dawley Rats

The Effect of Orexin-A on Cardiac Dysfunction Mediated by NADPH Oxidase-Derived Superoxide Anion in Ventrolateral Medulla

Orexin-A differentially modulates AMPA-preferring responses of ganglion cells and amacrine cells in rat retina.

Orexin A Activates Hypoglossal Motoneurons And Enhances Genioglossus Muscle Activity In Rats

Orexin A depolarises rat intergeniculate leaflet neurons through non-selective cation channels

Orexin-A Excites Airway Vagal Preganglionic Neurons Via Activation of Orexin Receptor Type 1 and Type 2 in Rats

Reinvestigation of the Effect of Orexin A on Catecholamine Release from Adrenal Chromaffin Cells

[Central Action of Orexins on Sympathetic Outflow and Cardiovascular Function with a Focus on the Paraventricular Nucleus of the Hypothalamus].

[Orexin-a Inhibits Γ-Aminobutyric Acid Current of Neonatal Rat Spinal Cord Ventral Horn Neurons by Activating OX1R, OX2R and Ca2+-independent PKC].

Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans